Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • Definition
      • Wikipedia Background
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

Hyperbolic tapering of antidepressants: where are we now?

by jlohrconsulting | Nov 10, 2025 | Uncategorized | 0 comments

Drug Ther Bull. 2025 Nov 9:dtb-2024-000065. doi: 10.1136/dtb.2024.000065. Online ahead of print.

NO ABSTRACT

PMID:41207697 | DOI:10.1136/dtb.2024.000065

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments